Recall: D-0789-2017

Class II - Potentially Harmful

Class IIClassification

2017-05-15Initiated

TerminatedStatus

Baxter Healthcare CorporationFirm

Product

Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48

Reason

Lack of assurance of sterility: customer complaints received for the presence of leaks.

Distribution

US and foreign countries: United Arab Emirates, Colombia, and Canada

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.